Motif Bio plc ADRs
MTFB
MTFB was delisted on the 16th of December, 2019.
4 hedge funds and large institutions have $8.51M invested in Motif Bio plc ADRs in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
33% more funds holding
Funds holding: 3 → 4 (+1)
24% less capital invested
Capital invested by funds: $11.2M → $8.51M (-$2.7M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$143K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$6.08K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$132 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$4.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $8.38M | – | – | – |
|
|
2
Jane Street
New York
| $129K | +$143K | +17,348 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $6K | +$6.08K | +739 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $1K | +$132 | +16 | +32% |
|
|
SM
5
Sabby Management
Miami Beach,
Florida
| – | -$4.6M | -755,875 | Closed |
|
MTFB Hedge Fund Activity: Q2 2017 in Review
4 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc ADRs (MTFB) for Q2 2017, worth a combined $8.51M — down 24% from $11.2M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new MTFB positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $143K. The largest seller was Sabby Management, exiting entirely with an estimated $4.6M sold.
- 4 institutional investors held Motif Bio plc ADRs (MTFB) as of Q2 2017, up from 3 in Q1 2017.
- Funds reported $8.51M of Motif Bio plc ADRs stock for Q2 2017, down 24% quarter-over-quarter.
- 2 funds opened new Motif Bio plc ADRs positions in Q2 2017 and 1 closed out, a net change of +1 holder.
- The largest Motif Bio plc ADRs buyer in Q2 2017 was Jane Street, an estimated $143K added.
- The largest Motif Bio plc ADRs seller in Q2 2017 was Sabby Management, an estimated $4.6M sold.
Based on aggregated 13F filings for Q2 2017.